These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. MET and MST1R as prognostic factors for classical Hodgkin's lymphoma. Wha Koh Y, Park C, Hyun Yoon D, Suh C, Huh J. Mod Pathol; 2013 Sep; 26(9):1172-82. PubMed ID: 23558571 [Abstract] [Full Text] [Related]
17. Proliferative index and CD15 expression in pediatric classical Hodgkin lymphoma. Dinand V, Malik A, Unni R, Arya LS, Pandey RM, Dawar R. Pediatr Blood Cancer; 2008 Feb; 50(2):280-3. PubMed ID: 17417795 [Abstract] [Full Text] [Related]
18. High c-Met expression in stage I-II pancreatic adenocarcinoma: proposal for an immunostaining scoring method and correlation with poor prognosis. Neuzillet C, Couvelard A, Tijeras-Raballand A, de Mestier L, de Gramont A, Bédossa P, Paradis V, Sauvanet A, Bachet JB, Ruszniewski P, Raymond E, Hammel P, Cros J. Histopathology; 2015 Nov; 67(5):664-76. PubMed ID: 25809563 [Abstract] [Full Text] [Related]